Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elan's Panoject Minifusor

This article was originally published in The Gray Sheet

Executive Summary

Two versions of the miniaturized modular infusion pump are granted 510(k) clearance, the Athlone, Ireland-based company announces May 19. Model 100 provides continuous drug delivery therapies while Model 200 is for continuous plus patient controlled analgesia. The ambulatory intravenous or subcutaneous infusion devices utilize Elan's Electro-Transport Drug Administration System (ETDAS) technology ("The Gray Sheet" Jan. 14, 1991, I&W-3) and "can be used for a variety of regimens to include pain management, insulin delivery, chemotherapy, antibiotic, anti-emetic, anticoagulation, tocolytic, AIDS, and chelation therapies," the company says. Since the system will be sold with empty cartridges which will be filled by the pharmacist or physician, FDA approval for use with specific drugs is not necessary. Panoject Minifusor was developed through Elan Medical Technologies Ltd., a joint venture with the Swiss company Pharmasys
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel